The five-month contract is with Retractable Technologies, a Texas-based medical devicemaker.
The low dead space safety syringes are needed to extract six doses of Pfizer’s COVID-19 vaccine from their vials, which were originally labeled to contain five.
HHS is able to exercise up to seven one-month extensions of the contract, which would cost a maximum of $92.7 million.
More articles on supply chain:
Pandemic spurring hospital shortage of pipette tips, sterile water, analysis finds
Millions of COVID-19 tests purchased by US going unused
US investigating millions of counterfeit N95 masks sent to hospitals
